CYTK Stock Price, Quote and News

CYTK

$--

--%

Analysis and statistics

Open
--
Previous Close
--
52 Week Change
--
Day Range
--
52 Week High/Low
--
Dividend Per Share
--
Market cap
--
EPS
--
Beta
--
Volume
--

About

CYTK.US is the stock ticker symbol for Cytokinetics, Incorporated, a biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. Cytokinetics is headquartered in South San Francisco, California and its common stock is listed on the Nasdaq Global Select Market. The company's research and development efforts are primarily concentrated on potential therapies for diseases like amyotrophic lateral sclerosis (ALS), hypertrophic cardiomyopathy (HCM), and spinal muscular atrophy (SMA).

Micron vs SanDisk: Which Stock Is Better Positioned for AI Growth?

Micron vs SanDisk compares HBM, DRAM and NAND exposure, recent results, valuation, risks and CFD trading considerations to help readers assess both stocks.

Julian Parker|--

AMD vs Intel vs Arm: Which Stock Could Benefit Most From the AI Inference Boom?

Compare AMD vs Intel vs Arm stocks in 2026, including AI inference exposure, financial growth, valuations, catalysts and investment risks.

Daniel Carter|--

AMD Joins the $1 Trillion Club as AI Demand Lifts Shares: AI Chip Stock Forecast and Outlook

AMD joined the $1 trillion club as Meta's Muse AI agent lit up inference demand. The full AMD stock forecast: analyst targets, valuation, risks, and how to trade it.

Julian Parker|--

British Pound Short-Term Outlook: Can GBP/USD Hold 1.33 as Fed–BoE Policy Divergence Widens?

British Pound Short-Term Outlook: Can GBP/USD hold 1.33 as Fed–BoE policy paths diverge? Explore the key catalysts, price scenarios, and CFD trading risks.

Julian Parker|--

Stellar XLM Price Prediction 2026, 2027 & 2030: Can XLM Reach $1?

Explore our Stellar XLM price prediction for 2026, 2027 and 2030, including adoption trends, major risks and whether XLM could reach $1.

Daniel Carter|--

The energy sector remains a hot topic & precious metals

Darius Anucauskas|--

Dollar to Mexican Peso Forecast 2026–2030: Can USD/MXN Break Above 17.50 as the Rate Gap Narrows?

Read our Dollar to Mexican Peso Forecast for 2026–2030, covering USD/MXN scenarios, rate-gap shifts, key price drivers and leveraged CFD trading risks.

Julian Parker|--

Factors

Drug Development Progress: Positive clinical trial results for Cytokinetics' heart failure drug, aficamten, tend to increase stock price. Conversely, trial failures or delays can negatively impact it.

Regulatory Decisions: FDA approval or rejection of aficamten significantly influences the stock. Approval leads to increased revenue potential and higher stock value.

Competition: Competing therapies for heart failure affect Cytokinetics' market share and profitability, thus influencing stock price.

Market Sentiment: General investor optimism or pessimism regarding biotech stocks influences Cytokinetics' valuation.

Financial Performance: Quarterly earnings reports, revenue growth, and profitability impact investor confidence and stock price.

Partnerships and Collaborations: Strategic alliances with pharmaceutical companies often boost investor confidence and stock value.

Economic Conditions: Broad economic factors like interest rates and inflation influence investor behavior and the overall stock market, including CYTK.US.

People Also Watch

Research

Is SpaceX a Good Stock to Buy in 2026?

Is SpaceX a good stock to buy in 2026? Explore its Starlink, launch and AI growth, valuation, analyst targets, risks and ways to trade SPCX.

Daniel Carter|--

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

What is the best gold stock to buy now? Compare six leading gold shares for 2026, including miners, streamers, key metrics, risks and CFD trading.

Daniel Carter|--

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Read our advanced CFD trading tools review covering charting, Trading Central, sentiment analysis, CFD calculators, economic calendars and risk tools.

Daniel Carter|--

Gold Price Trend 2024-2026: From $2,000 to Record Highs, What Comes Next?

Explore the gold price trend from 2024 to 2026, including historical performance, current analysis, key market drivers and 2026 forecast scenarios.

Daniel Carter|--

Upcoming IPOs 2026: The Biggest Companies to Watch and Major Listings So Far

Explore the upcoming IPOs 2026 list, including AI and tech companies preparing to go public, completed listings and ways to track new IPO dates.

Daniel Carter|--

Markets

Latest news

Gold Price Today: Gold Holds Near $4,280 After Strong US PMI Sends Treasury Yields Higher

Gold price today trades near $4,280 an ounce after strong US PMI data lifts Treasury yields and the dollar. Explore the Fed outlook and key market drivers.

Julian Parker|--

McDonald’s Stock Falls Nearly 5% as NEXT Investor Day Raises Turnaround Questions

McDonald’s shares fell 4.8% after its NEXT investor day. See its 2030 margin target, $8.5 billion franchisee support plan and the U.S. traffic questions ahead.

Julian Parker|--

Treasury Yields Spike After Strong US PMI as Nasdaq Falls More Than 1%

US Treasury yields surged after a strong September PMI reading raised expectations of another Fed rate hike. The Nasdaq fell more than 1% as stocks declined.

Julian Parker|--

Latest Education Articles

Risk Management 101

Trading involves risk, but understanding a few basics can help you manage it with more confidence. Here are some key risk management concepts to understand when considering leveraged trading.

Julian Parker|--

Best AI Stocks to Buy Now: 10 Best Performing AI Stocks to Watch in 2026

The 10 best performing AI stocks of 2026 — from Sandisk's 600% surge to Nvidia's $100bn quarters — where each fits in the AI supply chain, and how to trade them.

Julian Parker|--

Gold Scalping Strategy: How Scalping XAU/USD Works

Gold scalping strategy explained: why scalpers choose XAU/USD, timeframes and tools, the real cost maths, risk rules, and how to trade gold with Markets.com.

Julian Parker|--